Optimization of Radioligand Binding Assays for I1‐Imidazoline Sitesfn1
- 1 July 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 763 (1) , 163-168
- https://doi.org/10.1111/j.1749-6632.1995.tb32402.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A novel mechanism of action for hypertension control: Moxonidine as a selective I1-imidazoline agonistCardiovascular Drugs and Therapy, 1994
- ERRATUMThe FASEB Journal, 1994
- Increased imidazoline and α2 adrenergic binding in platelets of women with dysphoric premenstrual syndromesBiological Psychiatry, 1993
- Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medullaBiochemical Pharmacology, 1993
- A Second Generation of Centrally Acting Antihypertensive Agents Act on Putative I1-Imidazoline ReceptorsJournal of Cardiovascular Pharmacology, 1992
- Desipramine Lowers Tritiated Para-Aminoclonidine Binding in Platelets of Depressed PatientsArchives of General Psychiatry, 1991
- Binding of [3H]-p-aminoclonidine to α2adrenoceptor states plus a non-adrenergic site on human platelet plasma membranesBiochemical Pharmacology, 1991
- Greater Calmodulin-Dependent Regulation of Neurotransmitter Release and Vascular Responsiveness in Chronic Doca-Salt HypertensionAmerican Journal of Hypertension, 1989
- Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medullaEuropean Journal of Pharmacology, 1987